vidarabine phosphate has been researched along with Thrombocytopenia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeda, A; Matsushita, A; Nagai, K; Oida, T; Sugimoto, N; Takahashi, T; Watanabe, N; Yanai, M | 1 |
| Alcaraz, L; Bay, JO; Béal, D; Chollet, P; Cure, H; Fouassier, M; Plagne, R; Travade, P | 1 |
| Arima, N; Mizoguchi, H; Ohno, R; Shirakawa, S; Takatsuki, K; Tomonaga, M | 1 |
| Casper, ES; Kelson, D; Mittelman, A; Young, CW | 1 |
| Bodey, GP; Kavanagh, JJ; Krakoff, IH | 1 |
| Barlogie, B; Freireich, EJ; Kantarjian, H; Keating, MJ; Koller, C; McCredie, KB; Plunkett, W; Redman, J; Talpaz, M; Velasquez, W | 1 |
1 review(s) available for vidarabine phosphate and Thrombocytopenia
| Article | Year |
|---|---|
Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report.
Topics: Antimetabolites, Antineoplastic; Female; Heavy Chain Disease; Humans; Middle Aged; Radiography; Splenomegaly; Thrombocytopenia; Vidarabine Phosphate | 2004 |
1 trial(s) available for vidarabine phosphate and Thrombocytopenia
| Article | Year |
|---|---|
[Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Blood Cell Count; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Thrombocytopenia; Vidarabine Phosphate | 1999 |
4 other study(ies) available for vidarabine phosphate and Thrombocytopenia
| Article | Year |
|---|---|
Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphocytic leukemia.
Topics: Aged; Autoimmune Diseases; Drug Administration Schedule; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Thrombocytopenia; Vidarabine Phosphate | 1997 |
Phase I clinical trial of fludarabine phosphate (F-ara-AMP).
Topics: Adult; Aged; Arabinonucleotides; Bone Marrow; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia; Vidarabine Phosphate | 1985 |
Phase I study of fludarabine (2-fluoro-ara-AMP).
Topics: Adult; Aged; Agranulocytosis; Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Choriocarcinoma; Drug Evaluation; Female; Humans; Middle Aged; Pregnancy; Rhabdomyosarcoma; Sarcoma, Ewing; Thrombocytopenia; Uterine Cervical Neoplasms; Uterine Neoplasms; Vidarabine Phosphate | 1985 |
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Drug Evaluation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Neutropenia; Prognosis; Thrombocytopenia; Vidarabine Phosphate | 1989 |